Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
The ReCePI study is a Phase 3 clinical trial designed to evaluate the efficacy and safety of pathogen-reduced RBCs transfused for acute anemia in CVS compared to conventional RBCs, and to assess the clinical significance of treatment-emergent RBC antibodies
Monitoring and blood work Responsible IGF-1 LR3 use includes monitoring to catch potential issues early and optimize protocols based on individual response
$139.99 1 BOTTLE $139.99/ea 10% OFF 2 BOTTLES $125.99/ea 15% OFF 3 BOTTLES $118.99/ea Description FDA Disclosure & Intended Use Storage Instructions Reviews (0) RUO COA Description Description Dihexa 10mg Capsules | Research Peptide Frontier Peptide Labs Dihexa 10mg Capsules are manufactured exclusively for laboratory research and scientific investigation
Manufacturing EU cGMP facility CJC-1295 No DAC combined with Ipamorelin is an innovative peptide blend designed to stimulate the release of growth hormone (GH) by the pituitary gland
~10 min IGFBP affinity reduction / ~1,000-fold lower than native IGF-1 Primary receptor / IGF-1R (Kd ~1 nM)
US$ 26.28
US$ 29.89
US$ 27.81
